Literature DB >> 12356234

Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin.

B Lucey1, B Cryan, F O'Halloran, P G Wall, T Buckley, S Fanning.   

Abstract

Measurements were made of the susceptibility to six commonly prescribed antibiotics, including erythromycin, tetracycline and ciprofloxacin, of 130 isolates of Campylobacterjejuni and 15 isolates of Campylobacter coli cultured from human and poultry sources during 2000. The results were compared with the results from a collection of strains isolated between 1996 and 1998. The levels of resistance to erythromycin remained low, 2 per cent and 4.4 per cent for the human and poultry isolates, respectively. Resistance to tetracycline had increased to 31 per cent and 24.4 per cent from 13.9 per cent and 18.8 per cent for the human and poultry isolates, respectively. However, the resistance to ciprofloxacin of the strains isolated during 2000 had increased to 30 per cent, whereas between 1996 and 1998 there had been no resistance to this agent among human isolates, and only 3.1 per cent resistance among poultry isolates. The molecular basis for this resistance has been shown to be the result of a single amino acid substitution, Thr-86-Ile, in the gyrA subunit of DNA gyrase in Cjejuni. A subset of 59 isolates was tested by molecular methods and all of the 25 phenotypically resistant isolates possessed this substitution. None of the human isolates had been treated with ciprofloxacin before their laboratory isolation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356234     DOI: 10.1136/vr.151.11.317

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  8 in total

1.  Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta.

Authors:  J Y M Johnson; L M McMullen; P Hasselback; M Louie; G Jhangri; L D Saunders
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

2.  Antibiotic resistance of retail food and human Campylobacter isolates on the island of Ireland from 2001-2002.

Authors:  K McGill; D Cowley; L Moran; P Scates; A O'Leary; R H Madden; C Carroll; E McNamara; J E Moore; S Fanning; J D Collins; P Whyte
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

3.  Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure.

Authors:  Naidan Luo; Sonia Pereira; Orhan Sahin; Jun Lin; Shouxiong Huang; Linda Michel; Qijing Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-05       Impact factor: 11.205

4.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.

Authors:  Amera Gibreel; Veronica N Kos; Monika Keelan; Cathy A Trieber; Simon Levesque; Sophie Michaud; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.

Authors:  Amera Gibreel; Dobryan M Tracz; Lisa Nonaka; Trinh M Ngo; Sean R Connell; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 6.  Antibiotic resistance in Campylobacter: emergence, transmission and persistence.

Authors:  Taradon Luangtongkum; Byeonghwa Jeon; Jing Han; Paul Plummer; Catherine M Logue; Qijing Zhang
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

7.  Campylobacter spp. as a Foodborne Pathogen: A Review.

Authors:  Joana Silva; Daniela Leite; Mariana Fernandes; Cristina Mena; Paul Anthony Gibbs; Paula Teixeira
Journal:  Front Microbiol       Date:  2011-09-27       Impact factor: 5.640

8.  Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, France.

Authors:  Anne Gallay; Valérie Prouzet-Mauléon; Isabelle Kempf; Philippe Lehours; Leila Labadi; Christine Camou; Martine Denis; Henriette de Valk; Jean-Claude Desenclos; Francis Mégraud
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.